Fibbiani Martina, Ghelli Luserna DI Rorà Leonardo, Novelli Tommaso, Peroni Diego G
Section of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Section of Pediatrics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy -
Minerva Pediatr (Torino). 2022 Dec;74(6):724-732. doi: 10.23736/S2724-5276.22.07037-9. Epub 2022 Sep 30.
Human milk oligosaccharides (HMOs) act as prebiotics in the infant's gut and contribute to the relationship among the host and the gut microbiota. HMO are greatly present in the human milk and their benefit may include: reinforcement of the immune system with a better immune response to infective agents, improved resistance to infections of the gut, immunomodulation against food allergies, asthma, and atopic dermatitis and finally decreased the risk of chronic diseases. In this narrative review will discuss evidence present in literature regarding HMOs in human milk and their supplementation in infant formula.
人乳寡糖(HMOs)在婴儿肠道中作为益生元发挥作用,并有助于宿主与肠道微生物群之间的关系。HMOs大量存在于人乳中,其益处可能包括:增强免疫系统,对感染因子产生更好的免疫反应,提高对肠道感染的抵抗力,对食物过敏、哮喘和特应性皮炎进行免疫调节,最终降低患慢性病的风险。在这篇叙述性综述中,我们将讨论文献中有关人乳中HMOs及其在婴儿配方奶粉中的添加情况的证据。